Network Governance - Board of Directors

AllerGen NCE Inc. is governed by an independent Board of Directors. Board Directors are committed to the vision and mission of AllerGen, promoting an atmosphere where excellent research combines with industrial know-how to produce socio-economic benefits for Canadians.

Chair: Graham W.S. Scott, C.M., Q.C., CEO, Graham Scott Strategies Inc.

Scientific Director and CEO: Judah A. Denburg, MD, AllerGen NCE Inc.

Douglas Barber, PhD, P.Eng
Distinguished Professor-in-Residence, Faculty of Engineer, McMaster University

Howard Bergman, MD
Joseph Kaufman Chair in Geriatrics; Professor of Medicine, McGill University

Mark Bisby, PhD
Consultant

Deborah Danoff, MD
Professor, University of Ottawa

Patrick Deane, PhD
President and Vice-Chancellor, McMaster University

Christine Hampson, PhD
President and CEO, The Sandbox Project

John Gordon, PhD
Professor, Department of Medicine and Director, Canadian Centre for Health & Safety in Agriculture, University of Saskatchewan

Paul Lucas
President and CEO, GlaxoSmithKline Canada

Claude Roy, MD
Vice Chair, AllerGen Board of Directors; Gastroenterologist and Professor Emeritus, Hôpital Ste-Justine

Elinor Wilson, PhD
President and CEO, Assisted Human Reproduction Canada

ex-officio

Lisa Drouillard
Deputy Director, NCE Secretariat/NSERC

Lianne Soller, MSc
McGill University; President, AllerGen Student and New Professionals Network (ASNPN)

Diana Royce, EdD
Managing Director and COO, AllerGen NCE Inc.

Updated February 2012